Atlas Trials

Clinical Trial to Evaluate the Efficacy and Safety of DP-R212

Clinical trial NCT02955368 · WITHDRAWN

Trial details

NCT number
NCT02955368
Sponsor
Alvogen Korea
Status
WITHDRAWN
Phase
Phase 3
Study type
INTERVENTIONAL
HypertensionHypercholesterolemia
Start date
2017-02-01
Primary completion
2017-07-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.